MLPA

MLPA integrates electronic health records and genomic data using stochastic cellular automata to model tumor progression and pharmacological responses for personalized cancer simulation and treatment optimization.

Key Features:

• Multi-scale data integration: MLPA fully integrates macroscopic electronic health records (EHR) and microscopic genomic data for the first time.
• Stochastic cellular automata modeling: The framework employs stochastic cellular automata to model tumor progression and treatment efficacy dynamically.
• Metastasis simulation: The multi-scale strategy enables simulation of complex cancer behaviors including metastasis with remarkable precision.
• Gene pathway perturbation: MLPA simulates drug effects through gene pathway perturbation, with predicted tumor cell counts being within a 2.5% equivalence margin interval.
• Predictive validation: Validation using bioluminescent imaging from mice demonstrates exceptional predictive power, achieving a state-of-the-art R² value of 0.93 and fitting within 95% confidence intervals.
• Growth curve fidelity: The framework accurately captures tumors' characteristic S-shaped growth curve and shows high fidelity in simulating various scenarios from natural progression to aggressive growth and drug treatment responses.

Scientific Applications:

• Personalized cancer modeling: MLPA provides a platform for personalized cancer simulation based on individual human biological profiles.
• Treatment optimization: The framework optimizes therapy by simulating pharmacological responses to explore personalized treatment strategies.
• Precision oncology: MLPA serves as a powerful method for precision oncology by predicting tumor cell counts and drug treatment responses.
• Drug response prediction: The framework simulates various drug treatment responses with predicted tumor cell counts within a 2.5% equivalence margin interval.

Methodology:

MLPA employs stochastic cellular automata to dynamically model tumor progression and treatment efficacy. The framework integrates macroscopic electronic health records and microscopic genomic data using a multi-scale strategy. Validation was performed using bioluminescent imaging from mice.